Web Analytics

3 Latest Announced Rounds

  • $2,500,000
    Pre-Seed

    6 Investors

    Computer & Network Security
    Dec 23rd, 2025
  • $2,500,000
    Seed

    3 Investors

    Real Estate
    Dec 23rd, 2025
  • $2,000,000
    Seed

    2 Investors

    Financial Services
    Dec 23rd, 2025
$582.50M Raised in 21 Funding Rounds in the past 7 Days - View All

Funding Round Profile

BioLoomics, Inc.

start up
United States - Boulder, CO
  • 20/09/2023
  • Seed
  • $8,700,000

BioLoomics is a preclinical stage biotechnology company leveraging directed evolution of antibodies in human cells to create target degrading antibodies. Our proprietary tech combines single-cell bioassay engineering, robotics, and ML.
#synbio #directedevolution #antibodies


Related People

Doug ChapnickFounder

Doug Chapnick United States - Boulder, Colorado

Entrepreneur and biotechnology developer.